FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Ltd (formerly Fischer Chemic Limited) filed its annual disclosure under Regulation 31(4) of SEBI Takeover Regulations, declaring that no encumbrance (pledge, lien or similar charge) was created on any shares of the company — directly or indirectly — during the financial year ended March 31, 2025. The promoter and promoter group together hold 4,00,76,265 equity shares, representing 62.82% of total capital. This is held through M/s. Time Medical International Ventures Pte Ltd (Singapore-based) at 50.00%, Mr. Shankar Varadharajan at 10.82%, while Mr. Ravindran Govindan holds nil. The declaration was submitted by Mr. Shankar Varadharajan, Chief Operating Officer.
Shareholders get reassurance that promoter shares are free of any pledge or encumbrance, removing a common risk trigger. With promoter holding steady at 62.82%, there is no immediate threat of margin call or forced selling, which is a mildly positive governance signal for retail investors.